Components

Drugs Demand Reduction

3rd Meeting Adaptation and validation of quality and evidence-based criteria in Caribbean countries

Drugs Demand Reduction


3rd Meeting Adaptation and validation of quality and evidence-based criteria in Caribbean countries
Start date
13/06/19
End Date
14/06/19
Place
Paramaribo, Suriname

Closure of the validation exercise of the quality criteria (prevention and treatment) carried out throughout COPOLAD II by the Caribbean countries concerned, presentation of results and plans for the future development of accreditation frameworks for quality assurance. This is the third meeting of Caribbean countries working on the adaptation and validation of quality and evidence-based criteria in drug demand reduction. Suriname hosts this new meeting, with the presence of seven countries of the Caribbean region, on 13 and 14 June in Paramaribo. Caribbean centers working on demand reduction have validated Minimum Quality Criteria in prevention and treatment. COPOLAD monitors this process, initiated in 2016, which after three years, shares the results of the piloting exercise.

Under the leadership of the National Drug Council (NDC) of Trinidad and Tobago, on this occasion, 25 participants from Antigua and Barbuda, Bahamas, Dominica, Guyana, Jamaica, Saint Lucia, Trinidad and Tobago, together with the Pan American Health Organization (PAHO) and the Inter-American Drug Abuse Control Commission (CICAD-OAS), who serve as advisors to the working group, under COPOLAD monitoring.

The experts of this working group, to which the indicated Caribbean countries belong, were invited to carry out a process of validation of the Minimum Quality Criteria in one of the fields of Demand Reduction: prevention or treatment, of the different Centers of the countries. In this sense, the main objective of this meeting will be to share the advances, findings and achievements that have been achieved during the validation / piloting exercise by the different member countries of the group, as well as to be able to evaluate possible future actions.

Operative Dimension

Code
2.1.2.3
Year
2019
Component
C2 - Drugs Demand Reduction
Execution Level
Completed
Activity Types
Associated operational objectives

2.2 - Facilitate the validation and endorsement of quality criteria agreed during C1, for programmes implemented in: prevention; treatment, harm reduction; and social (re)integration/ rehabilitation.

Institutions

NDC - National Drug Council Trinidad and Tobago

Leader

Institution Website
PAHO/WHO - Pan American Health Organization Supranational

Collaborator

Institution Website
CICAD/OAS - Inter-American Drug Abuse Control Commission Supranational

Collaborator

Institution Website
NAR - Executive Office of the National Anti - Drug Council Surinam

Host

Institution Website

Participant Institutions

This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu

If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.

Participation

Participation for regions

Participation of countries for region

Participants

This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu

If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.

Restricted documents

This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu

If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.

Photo gallery

Related activities

  • 1st meeting for the validation of basic quality and evidence-based criteria for treatment programmes

    28/03/17 - 30/03/17

    Santiago de Chile

    Go to activity
  • 1st meeting for the validation of quality and evidence-based advanced criteria for treatment and harm reduction programmes

    29/03/17 - 30/03/17

    Santiago de Chile

    Go to activity
  • 1st meeting Validation of quality and evidence-based criteria for prevention programmes

    26/09/17 - 27/09/17

    San José, Costa Rica

    Go to activity
  • 1st meeting Adaptation and validation of quality and evidence-based criteria in Caribbean countries

    03/10/17 - 04/10/17

    Georgetown, Guyana

    Go to activity
  • 2nd Meeting Adaptation and validation of quality and evidence-based criteria in Caribbean countries

    20/04/18

    Kingston, Jamaica

    Go to activity
  • 2nd Meeting for the validation of basic and advanced quality and evidence-based criteria for treatment and prevention programmes

    20/11/18 - 22/11/18

    Santiago, Chile

    Go to activity